Periodontitis response to anti-TNF therapy in ankylosing spondylitis

Journal of Clinical Rheumatology

Volumn 21, Issue 7, 2015, Pages 341-345

  Fabri, Gisele Maria C ^a   Pereira, Rosa Maria R ^b   Savioli, Cynthia ^b   Saad, Carla G S ^b   De Moraes, Julio Cesar B ^b   Siqueira, Jose Tadeu T ^b   Bonfa, Eloisa ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ankylosing spondylitis; Periodontal disease; Periodontium; Rheumatic diseases; Rheumatoid arthritis; TNF alpha

Indexed keywords

C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS DISEASE METROLOGY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAS28; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GINGIVITIS; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; MOUTH HYGIENE; MUSCULOSKELETAL DISEASE ASSESSMENT; PERIODONTITIS; PERIODONTIUM; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; COHORT ANALYSIS; COMPLICATION; MIDDLE AGED; PATHOLOGY; PERIODONTICS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTITIS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84942510833     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0000000000000300     Document Type: Article

References (40)

1. Waykole YP, Doiphode SS, Rakhewar PS, et al. Anticytokine therapy for periodontal diseases: where are we now? J Indian Soc Periodontol. 2009;13:64-68.
2. Herman S, Kronke G, Schett G. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy. Trends Mol Med. 2008;14: 245-253.
3. Braun J, Kalden JR. Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2009;27:S164-S167.
4. Bodine PV, Komm BS. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord. 2006;7:33-39.
5. Daoussis D, Liossis SN, Solomou EE, et al. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2010;62: 150-158.
6. Krishnan V, Bryant HU, Macdougald OA. Regulation ofbone mass by Wnt signaling. J Clin Invest. 2006;116:1202-1209.
7. Pischon N, Pischon T, Gulmez E, et al. Periodontal disease in patients with ankylosing spondylitis. Ann Rheum Dis. 2010;69:34-38.
8. Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: a review. J Periodontol. 2005;76:2066-2074.
9. Armitage GC. The complete periodontal examination. Periodontol 2000. 2004;34:22-33.
10. Braun J, Baraliakos X. Imaging of axial spondyloarthritis including ankylosing spondylitis. Ann Rheum Dis. 2011;70(Suppl 1):i97-i103.
11. Braun J, Van den Berg R, Baraliakos X, et al. Updateof the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70:896-904.
12. Assuma R, Oates T, Cochran D, et al. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol. 1998;160:403-409.
13. Savioli C, Ribeiro AC, Fabri GM, et al. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheumatol. 2012;18:180-184.
14. Pers JO, Saraux A, Pierre R, et al. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Periodontol. 2008;79:1645-1651.
15. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361-368.
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1998;31:315-324.
17. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4:1-6.
18. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286-2291.
19. Calin A, Jones SD, Garrett SL, et al. Bath Ankylosing Spondylitis Functional Index. Br J Rheumatol. 1995;34:793-794.
20. Jenkinson TR, Mallorie PA, Whitelock HC, et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol. 1994;21:1694-1698.
21. Prevoo ML, van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-48.
22. Aletaha D, Landewe R, Karonitsch T, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum. 2008;59:1371-1377.
23. Van der Heijde DM, van 't Hof MA, van Riel PL, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990;49:916-920.
24. Ferraz MB, Oliveira LM, Araujo PM, et al. Cross-cultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol. 1990;17:813-817.
25. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25:229-235.
26. O'Leary T. The periodontal screening examination. J Periodontol. 1967;38: 617-624.
27. Mayer Y, Balbir-Gurman A, Machtei EE. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J Periodontol. 2009;80:1414-1420.
28. Chakrapani S, Sirisha K, Srilalitha A, et al. Choice of diagnostic and therapeutic imaging in periodontics and implantology. J Indian Soc Periodontol. 2013;17:711-718.
29. Ball J. Enthesopathy ofrheumatoid and ankylosing spondylitis. Ann Rheum Dis. 1971;30:213-223.
30. Lories RJ, Baeten DL. Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2009;27: S10-S14.
31. Ivanovski S, Gronthos S, Shi S, et al. Stem cells in the periodontal ligament. Oral Dis. 2006;12:358-363.
32. Guo W, Chen L, Gong K, et al. Heterogeneous dental follicle cells and the regeneration of complex periodontal tissues. Tissue Eng Part A. 2011;18: 459-470.
33. Heo JS, Lee SY, Lee JC. Wnt/beta-catenin signaling enhances osteoblastogenic differentiation from human periodontal ligament fibroblasts. Mol Cells. 2010;30:449-454.
34. Rooker SM, Liu B, Helms JA. Role of Wnt signaling in the biology of the periodontium. Dev Dyn. 2010;239:140-147.
35. Pedersen SJ, Chiowchanwisawakit P, Lambert RG, et al. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J Rheumatol. 2011;38:1349-1354.
36. Jager A, Gotz W, Lossdorfer S, et al. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro. J Periodontal Res. 2010;45:246-254.
37. Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13:156-163.
38. Saad CG, Ribeiro AC, Moraes JC, et al. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? Arthritis Res Ther. 2012;14:R216.
39. Appel H, Ruiz-Heiland G, Listing J, et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2009;60:3257-3262.
40. van der Heijde D, Landewe R, Baraliakos X, et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 2008;58:3063-3070.